Clinical Trials Arena on MSN

Agios reports top line Phase III trial data of mitapivat for sickle cell disease

The study achieved its primary endpoint of haemoglobin response, with mitapivat demonstrating an improvement versus placebo.

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

The top-line data from the first cohort demonstrate a favorable safety profile, with no serious adverse events reported and the treatment generally well-tolerated across all participants. Additionally ...

Genelux: An Oncolytic Virus Player About To Cross The Phase 3 Finish Line, But On Shaky Ground

Get the latest insights on Genelux Corp's oncolytic virus pipeline, phase 3 trial update, and financial outlook.
ascopubs.org

New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma.

Intravesical recombinant BCG followed by perioperative chemo-immunotherapy for patients with muscle-invasive bladder cancer (MIBC): A multicenter, single arm phase 2 trial (SAKK 06/19). This is an ...

Zymeworks Surges On Positive Ziihera Phase 3 Data: Expanding First-Line GEA Opportunity

Zymeworks surges on positive Phase 3 Ziihera data in HER2-positive cancer. Discover key catalysts and what’s next for ZYME stock.
Nature

Phase Shifters and Transmission Line Technologies

Phase shifters and transmission line technologies are integral components in modern RF and microwave engineering, enabling precise control of signal phase for applications ranging from beamforming in ...